TipRanks
Quantum Computing Inc. (MX:QUBT)
:QUBT
Mexico Market
EarningsQ2 2026 Earnings Report

Quantum Computing (QUBT) Q2 2026 Earnings Report

1 Followers

MX:QUBT Q2 2026 EPS Results

Actual EPS-$0.86
Consensus EPS-$0.60
Beat/MissMissed by -$0.26
One Year Ago EPS-$4.48

MX:QUBT Q2 2026 Revenue Results

Actual Revenue$95.61M
Expected Revenue$88.74M
Beat/MissBeat by +$6.87M
YoY Revenue Growth+9000.00%

Earnings Announcement Details

QuarterQ2 2026
Date08/10/2026
TimeAfter Close
Conference CallMonday, August 10, 2026
MX:QUBT Upcoming Earnings
Quantum Computing's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:QUBT Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 10, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicated significant strategic progress: major acquisitions to expand manufacturing and packaging capabilities, commercialization milestones (Dirac-3 delivery, Neurawave readiness and orders), a materially larger revenue base year-over-year, and a strong balance sheet (~$1.3B cash/investments). At the same time, the business is investing heavily—operating expenses rose 114%—reports a continued net loss (albeit improved due to noncash derivative valuation), faces lumpy revenue recognition and integration/CAPEX needs, and remains concentrated in government subcontracting. On balance the update shows strong momentum and financial flexibility to execute the growth strategy, tempered by near-term expense and execution risks.
Company Guidance
Management gave no formal forward-looking revenue guidance but emphasized integration of three H1 acquisitions and scaling manufacturing while citing many specific metrics: Q2 revenue was $5.6M (vs. $61k in Q2’25 and $3.7M in Q1’26), operating expenses $21.8M (vs. $10.2M), acquisition-related transaction costs ≈$7.3M, interest/other income $13M (vs. $1.8M), net loss $11.8M or $0.05/share (vs. $36.5M or $0.26), and a derivative mark-to-market loss of $1.7M (vs. $28M); balance sheet: total assets ≈$1.6B, cash & investments ≈$1.3B (down from ~$1.5B YE’25), liabilities $47.2M, and shareholders’ equity $1.6B; they used ≈$180M cash for acquisitions, report a contract backlog of ≈$42.5M (contracts typically 12–18 months, sufficient into Q3’27 if nothing new), noted Enhanced’s ~60k wafers/year capacity and a potential Fab-2 upgrade capex of $50–100M (roughly $75M estimate, unlikely this year), cited pro-forma targets (QCI pre-Enhanced model $20–25M revenue this year; Enhanced historical H1 ≈$16M; 2027 earn-out target $35M), and highlighted commercial wins including a Planck PO for 5 Neurawave units with >$10M potential program value and delivery of Dirac‑3.
Large YoY Revenue Increase
Revenue for Q2 2026 was $5.6M versus $61K in Q2 2025, representing an approximately 9,000%+ year-over-year increase and a sequential increase of ~51% from Q1 2026 ($3.7M).
Commercial Product Milestones and Orders
Dirac-3 delivered and installed at a global consulting firm; Neurawave declared commercially ready; initial purchase order from Planck Dynamics for 5 Neurawave systems with potential aggregate program value > $10M; purchase order from a leading university for Quantum secure communications system.
Strategic Acquisitions and Manufacturing Scale-Up
Completed three strategic acquisitions (including Enhanced Semiconductor, Luminar Semiconductor, and NuCrypt) in H1 2026, enabling Fab-2 launch, expanding advanced packaging, photonics, and US-based semiconductor manufacturing capabilities and bringing experienced engineering talent.
Strong Balance Sheet and Large Cash/Investment Position
Total assets approx. $1.6B and cash, cash equivalents and investments approx. $1.3B as of 06/30/2026, providing financial flexibility to fund acquisitions, R&D, and manufacturing expansion despite acquisition spend.
Improved Net Loss Driven by Derivative Valuation
Net loss for Q2 2026 was $11.8M (loss of $0.05 per share) versus a $36.5M loss ($0.26 per share) in Q2 2025; major improvement driven by a much smaller mark-to-market derivative loss in Q2 2026 ($1.7M) versus $28M in Q2 2025.
Backlog and Contract Visibility
Contract backlog of approximately $42.5M as of June 30, 2026, representing multi-quarter revenue visibility across 12–18 month project horizons and providing a baseline of future work.
Higher Interest and Other Income from Larger Cash Position
Interest and other income rose to $13M in Q2 2026 from $1.8M in Q2 2025, an increase of ~622%, reflecting returns on a materially larger cash and investment balance.
Commercial Go-To-Market Investments
Hired a new Chief Revenue Officer and plans to expand the salesforce to accelerate commercial penetration across government and commercial markets.

MX:QUBT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 18, 2026
2026 (Q3)
-0.69 / -
0.172―
2026 (Q2)
-0.60 / -0.86
-4.47880.77% (+3.62)
2026 (Q1)
-0.81 / -0.34
1.895-118.18% (-2.24)
2025 (Q4)
-0.59 / -0.17
-8.09597.87% (+7.92)
2025 (Q3)
-0.98 / 0.17
-1.033116.67% (+1.21)
2025 (Q2)
-0.95 / -4.48
-1.033-333.33% (-3.44)
2025 (Q1)
-1.21 / 1.89
-1.378237.50% (+3.27)
2024 (Q4)
-0.86 / -8.10
-1.55-422.22% (-6.55)
2024 (Q3)
- / -
-1.55―
2024 (Q2)
-1.38 / -1.03
-1.5533.33% (+0.52)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed